Contraception
RSSArticles
-
Weathering the COVID-19 Pandemic Proved Challenging for Providers
Family planning centers across the United States focused on telehealth and found creative ways to serve their clients after the COVID-19 pandemic rolled across North America in the winter and spring of 2020. Contraceptive Technology Update asked clinic leaders to participate in a Q&A about their operations during the pandemic.
-
Special Report: Pandemic Response and Preparedness
Family planning clinics and contraceptive providers have had to search for creative ways to stay open and continue providing services during the COVID-19 pandemic. Contraceptive Technology Update interviewed seven family panning providers in this Q&A special report.
-
Safely Screen Patients for Intimate Partner Violence During Telehealth Visits
As telehealth visits play an important role in family planning during the pandemic, providers should be aware their patients might be closely monitored by their partners, especially in cases of intimate partner violence. Abusers might check the woman’s phone messages, digital communication, and apps with messaging.
-
Chief Reasons Domestic Violence Is Increasing
Pandemics, economic recessions, natural disasters, and other crises can lead to increases in intimate partner violence or domestic violence for a variety of reasons. Women and children are particularly vulnerable when disasters such as COVID-19 strike.
-
With Domestic Violence Increasing, Family Planning Providers Should Screen for Signs
Recent research suggests domestic violence may be increasing during the COVID-19 pandemic. Family planning clinics will need creative techniques to screen for signs as many visits continue through telehealth.
-
Etonogestrel Contraceptive Implant and VTE in Postpartum Women
In this national retrospective cohort study of postpartum women, use of the etonogestrel contraceptive implant immediately
postpartum was not associated with an increased rate of readmission for venous thromboembolism within 30 days of delivery. -
Why Has the Female Condom Not Been Widely Adopted in the United States?
Contraceptive Technology Update asked two researchers involved in a new study about female (internal) condom use to answer some questions about the use of this contraceptive method in the United States.
-
Study: Women Use Female Condoms More When Their Partners Approve
Female (internal) condoms were hailed as a method that gave women control over their disease protection. But one factor was overlooked: Women’s reproductive health decisions are influenced by male partners.
-
Marketing a Male Contraceptive Plays Role in Availability
The marathon race for finding an effective and safe male contraceptive has reached a hurdle that was not as much of a barrier for the research race to bring the first female contraceptive to market: Someone needs to prove men want their own contraceptive and will use whatever method succeeds.
-
Fledgling Research Holds Promise for Safe, On-Demand Male Contraceptive Pill
Researchers have found a possible way to target soluble adenylyl cyclase (sAC:ADY10), which is essential for male fertility.